<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    TCR2 Therapeutics Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About TCR2 Therapeutics Inc.

    TCR² is an innovative immunotherapy company developing the next generation of T cell therapies for patients suffering from cancer. Our proprietary TRuC™ (TCR Fusion Construct) T cells – a novel T cell therapy platform – reprogram the natural T cell receptor complex to recognize and kill cancer cells using the full power of T cell signaling pathways independent of HLA. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $347,800,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Garry Menzel, PhD and MBA
    • FOUNDED
      2015
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Amarantus Bioscience Holdings, Inc.

    Amarantus Bioscience Holdings, Inc.

    Amarantus BioSciences is a development-stage, publicly-traded biotechnology compan...

    Amarantus BioSciences is a development-stage, p...

    Amount Raised:    $4,300,000
    Fundraising Status:    VT
    Filing Type:    PR
    Actual Natural Health & Wellness Products, Inc.

    Actual Natural Health & Wellness Products, Inc.

    The ONLY patented, drug free, saline free, all natural, DAILY nasal hygiene wash, ...

    The ONLY patented, drug free, saline free, all ...

    Amount Raised:    $538.00
    Fundraising Status:    EC
    Filing Type:    CF
    Apellis Pharmaceuticals, Inc.

    Apellis Pharmaceuticals, Inc.

    We are a clinical-stage biopharmaceutical company focused on the development of no...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Esperion Therapeutics, Inc.

    Esperion Therapeutics, Inc.

    Esperion is a pharmaceutical company passionately committed to developing and comm...

    Esperion is a pharmaceutical company passionate...

    Filing Type:    PU
    ImmunoGen, Inc.

    ImmunoGen, Inc.

    ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to ...

    ImmunoGen is developing the next generation of ...

    Filing Type:    PU
    Pulmatrix, Inc.

    Pulmatrix, Inc.

    Pulmatrix is a clinical stage biopharmaceutical company developing innovative inha...

    Pulmatrix is a clinical stage biopharmaceutical...

    Filing Type:    PU
    OncoSec Medical Incorporated

    OncoSec Medical Incorporated

    OncoSec Medical Incorporated is a clinical-stage biotechnology company focused on ...

    OncoSec Medical Incorporated is a clinical-stag...

    Filing Type:    PU
    Compugen Ltd.

    Compugen Ltd.

    Compugen is a drug discovery company with a unique, broadly applicable, predictive...

    Compugen is a drug discovery company with a uni...

    Filing Type:    PU
    Atara Biotherapeutics, Inc.

    Atara Biotherapeutics, Inc.

    Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy ...

    Atara Biotherapeutics is a leading off-the-shel...

    Filing Type:    PU
    Alpine Immune Sciences, Inc.

    Alpine Immune Sciences, Inc.

    Alpine is a development-stage specialty pharmaceutical company focused on discover...

    Alpine is a development-stage specialty pharmac...

    Filing Type:    PU
    Sunesis Pharmaceuticals, Inc.

    Sunesis Pharmaceuticals, Inc.

    Sunesis is a biopharmaceutical company focused on the development and commercializ...

    Sunesis is a biopharmaceutical company focused ...

    Filing Type:    PU
    Sierra Oncology, Inc.

    Sierra Oncology, Inc.

    Sierra Oncology is a clinical stage drug development company advancing targeted th...

    Sierra Oncology is a clinical stage drug develo...

    Filing Type:    PU
    ©2024 National Investor Network. All Rights Reserved.